Law Siu Kan, Wang Yanping, Lu Xinchen, Au Dawn Ching Tung, Chow Wesley Yeuk Lung, Leung Albert Wing Nang, Xu Chuanshan
Key Laboratory of Molecular Target & Clinical Pharmacology and the State & NMPA Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences, Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou, China.
Faculty of Science and Technology, The Technological and Higher Education Institute of Hong Kong, Hong Kong, Hong Kong SAR, China.
Front Pharmacol. 2022 Oct 3;13:1016004. doi: 10.3389/fphar.2022.1016004. eCollection 2022.
Obesity is a leading worldwide health threat with ever-growing prevalence, it promotes the incidence of various diseases, particularly cardiovascular disease, metabolic syndrome, diabetes, hypertension, and certain cancers. Traditional Chinese Medicine (TCM) has been used to control body weight and treat obesity for thousands of years, Chinese medicinal herbs provide a rich natural source of effective agents against obesity. However, some problems such as complex active ingredients, poor quality control, and unclear therapeutic mechanisms still need to be investigated and resolved. Prodrugs provide a path forward to overcome TCM deficiencies such as absorption, distribution, metabolism, excretion (ADME) properties, and toxicity. This article aimed to review the possible prodrugs from various medicinal plants that demonstrate beneficial effects on obesity and seek to offer insights on prodrug design as well as a solution to the global obesity issues.
肥胖是一种在全球范围内日益普遍且对健康构成主要威胁的疾病,它会促使各种疾病的发生,尤其是心血管疾病、代谢综合征、糖尿病、高血压和某些癌症。数千年来,中医一直被用于控制体重和治疗肥胖症,中草药为对抗肥胖提供了丰富的天然有效成分来源。然而,诸如活性成分复杂、质量控制不佳以及治疗机制不明确等一些问题仍有待研究和解决。前体药物为克服中药在吸收、分布、代谢、排泄(ADME)特性和毒性等方面的不足提供了一条途径。本文旨在综述各种药用植物中可能对肥胖症有有益作用的前体药物,并试图为前体药物设计提供见解以及解决全球肥胖问题的方案。